Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflunomide for Maintenance of Remission in IgG4 Related Disease
NCT02703194Phase 4Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Mar 2016
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of leflunomide in IgG4-related disease (IgG4-RD), sponsored by Chinese PLA General Hospital. Started Mar 2016; status: completed.
02
Drugs
leflunomide
03
Conditions
IgG4-related disease (IgG4-RD)
Beyond the preview
Go deeper on NCT02703194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02703194.